Q527-- Fludeoxyglucose FDG F18 (Pharmaceutical Product for PET CT Dose for Patient Care)

Active

Contract Opportunity

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) subpart 12.6, Streamlined Procedures for Evaluation and Solicitation for Commercial Items, in conjunction with FAR Part 13.5, Simplified Acquisition Procedures for Certain Items as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a written solicitation document will not be issued. This requirement will be evaluated using the comparative evaluation process outlined in FAR 13.106-2 (b) (3), where quotations will be compared to one another to determine which provides the best benefit to the Government.

The combined synopsis/solicitation number is 36C25625Q0944.

This solicitation is a request for quotations (RFQ). The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2025-03 (effective 01/17/202).

This requirement is solicited as Unrestricted.

The associated North American Industrial Classification System (NAICS) code for this procurement is 325412 with a small business size standard of 1300 Employees.

Period of Performance: 5 (five) years.

The Network Contracting Office 16 is seeking Pharmaceutical Preparation Manufacturing (Fludeoxyglucose FDG F 18 for PET CT) in accordance with the Statement of Work for the Central Arkansas Veterans Healthcare System s John L. McClellan Memorial Veterans Hospital in Little Rock, AR.

All questions regarding this RFQ must be submitted electronically via e-mail to arlene.blade@va.gov. Questions must be received no later than June 27, 2025 at 8:00 AM CST. No further questions will be accepted after that date and time.

Quotes shall be submitted electronically via email to the Contracting Officer, Arlene A. Blade, at arlene.blade@va.gov no later than 8:00 am CST on July 8, 2025. Quoter s shall include RFQ Number 36C25625Q0944 in the subject line.

You are reminded that representatives from your company SHALL NOT contact any VA Medical Center employees to discuss this RFQ during this RFQ process. All questions and concerns regarding this RFQ shall be directed to the Contracting Officer (CO). No telephone calls will be accepted.

Attachments/Links